These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15229305)

  • 21. Association of parental heart failure with risk of heart failure in offspring.
    Lee DS; Pencina MJ; Benjamin EJ; Wang TJ; Levy D; O'Donnell CJ; Nam BH; Larson MG; D'Agostino RB; Vasan RS
    N Engl J Med; 2006 Jul; 355(2):138-47. PubMed ID: 16837677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of progression to hypertension in a low-income Mexican population with prehypertension and normal blood pressure.
    Jimenez-Corona A; Lopez-Ridaura R; Stern MP; Gonzalez-Villalpando C
    Am J Hypertens; 2007 Sep; 20(9):929-36. PubMed ID: 17765131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of aldosterone-to-renin ratio with hypertension differs by sodium intake: the Ohasama study.
    Satoh M; Kikuya M; Hosaka M; Asayama K; Inoue R; Metoki H; Tsubota-Utsugi M; Hara A; Hirose T; Obara T; Mori T; Totsune K; Hoshi H; Mano N; Imai Y; Ohkubo T
    Am J Hypertens; 2015 Feb; 28(2):208-15. PubMed ID: 24958786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
    Brilla CG; Matsubara LS; Weber KT
    J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.
    Letavernier E; Peyrard S; Amar L; Zinzindohoué F; Fiquet B; Plouin PF
    J Hypertens; 2008 Sep; 26(9):1816-23. PubMed ID: 18698217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.
    Mosterd A; D'Agostino RB; Silbershatz H; Sytkowski PA; Kannel WB; Grobbee DE; Levy D
    N Engl J Med; 1999 Apr; 340(16):1221-7. PubMed ID: 10210704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
    Catena C; Colussi GL; Marzano L; Sechi LA
    Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure.
    Arnlöv J; Pencina MJ; Nam BH; Meigs JB; Fox CS; Levy D; D'Agostino RB; Vasan RS
    Circulation; 2005 Sep; 112(12):1719-27. PubMed ID: 16157770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.
    Vasan RS; Larson MG; Benjamin EJ; Evans JC; Levy D
    N Engl J Med; 1997 May; 336(19):1350-5. PubMed ID: 9134875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
    Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldosteronism and hypertension.
    Calhoun DA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1039-45. PubMed ID: 17699324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring.
    Elias MF; Sullivan LM; Elias PK; D'Agostino RB; Wolf PA; Seshadri S; Au R; Benjamin EJ; Vasan RS
    Hypertension; 2007 Mar; 49(3):439-45. PubMed ID: 17224472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
    Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
    J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
    Pouleur AC; Uno H; Prescott MF; Desai A; Appelbaum E; Lukashevich V; Smith BA; Dahlöf B; Solomon SD;
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):483-90. PubMed ID: 21746765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lead exposure and conventional and ambulatory blood pressure: a prospective population study. PheeCad Investigators.
    Staessen JA; Roels H; Fagard R
    JAMA; 1996 May 22-29; 275(20):1563-70. PubMed ID: 8622247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone-to-renin ratio and nocturnal blood pressure decline in a general population: the Ohasama study.
    Satoh M; Kikuya M; Ohkubo T; Mori T; Metoki H; Hashimoto T; Hara A; Utsugi MT; Hirose T; Obara T; Inoue R; Asayama K; Kanno A; Totsune K; Hoshi H; Satoh H; Imai Y
    J Hypertens; 2011 Oct; 29(10):1940-7. PubMed ID: 21841498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone-to-renin ratio and home blood pressure in subjects with higher and lower sodium intake: the Ohasama study.
    Satoh M; Kikuya M; Hara A; Ohkubo T; Mori T; Metoki H; Utsugi MT; Hirose T; Obara T; Inoue R; Asayama K; Totsune K; Hoshi H; Satoh H; Imai Y
    Hypertens Res; 2011 Mar; 34(3):361-6. PubMed ID: 21124331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.